Merck Cost Cuts Round Two: Sales & Marketing Take A Hit
This article was originally published in The Pink Sheet Daily
Executive Summary
Company announces additional $1 bil. in savings, mostly from reductions in marketing and administrative costs.
You may also be interested in...
Merck Aims To Duplicate Januvia Launch Success In 2007
Launches for Janumet, Arcoxia and Emend IV are keys to continuing the momentum of firm’s turnaround plan, CEO Clark says.
Merck Aims To Duplicate Januvia Launch Success In 2007
Launches for Janumet, Arcoxia and Emend IV are keys to continuing the momentum of firm’s turnaround plan, CEO Clark says.
J&J Pharma Sales Force Reduced As Part Of Efficiencies Program
Firm says it has implemented a "modest" sales force reduction.